Article ; Online: Comment on Kutz et al. Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes. Diabetes Care 2023;46:2004-2014.
2024 Volume 47, Issue 4, Page(s) e32–e33
MeSH term(s) | Humans ; Diabetes Mellitus, Type 2/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Dipeptidyl-Peptidase IV Inhibitors/adverse effects ; Glucagon-Like Peptide-1 Receptor Agonists ; Frailty ; Hypoglycemic Agents/adverse effects |
---|---|
Chemical Substances | Sodium-Glucose Transporter 2 Inhibitors ; Dipeptidyl-Peptidase IV Inhibitors ; Glucagon-Like Peptide-1 Receptor Agonists ; Hypoglycemic Agents |
Language | English |
Publishing date | 2024-03-22 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 441231-x |
ISSN | 1935-5548 ; 0149-5992 |
ISSN (online) | 1935-5548 |
ISSN | 0149-5992 |
DOI | 10.2337/dc23-2420 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1434: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 365: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.